Peptide–MHC Complexes Assembled Following Multiple Pathways:: An Opportunity for the Design of Vaccines and Therapeutic Molecules
- 31 May 1997
- journal article
- review article
- Published by Elsevier BV in Human Immunology
- Vol. 54 (2), 137-147
- https://doi.org/10.1016/s0198-8859(97)00080-3
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest?Immunology Today, 1997
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- How MHC Class II Molecules Acquire Peptide Cargo: Biosynthesis and Trafficking through the Endocytic PathwayAnnual Review of Cell and Developmental Biology, 1995
- Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentationEuropean Journal of Immunology, 1995
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.JCI Insight, 1995
- Separation of subcellular compartments containing distinct functional forms of MHC class II.The Journal of cell biology, 1994
- Characterization of peptides bound to extracellular and intracellular HLA-DR1 moleculesHuman Immunology, 1993
- MHC class II-associated invariant chain contains a sorting signal for endosomal compartmentsCell, 1990
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Carrier-priming leads to hapten-specific suppressionNature, 1980